Farringdon Capital’s Ventyx Biosciences VTYX Stock Holding History

Farringdon Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,461	Closed	-$18.9K	–	608
2025 Q1	$18.9K	Buy	+16,461	New	+$28.3K	0.01%	323

Other funds holding VTYX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Farringdon Capital's VTYX Position: Q2 2025 in Review

Farringdon Capital sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 16,461 shares — an estimated $18.9K sold.

Farringdon Capital first reported a position in VTYX in Q1 2025 and held it in 1 quarter. The position peaked at $18.9K in Q1 2025. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

Farringdon Capital reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
Farringdon Capital sold 16,461 Ventyx Biosciences shares in Q2 2025, an estimated $18.9K.
Farringdon Capital first reported a position in Ventyx Biosciences in Q1 2025 and held it in 1 quarter.
Farringdon Capital's Ventyx Biosciences position peaked at $18.9K in Q1 2025.
114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Farringdon Capital's 13F filing for Q2 2025, filed 14 Aug 2025.